Stock Earnings

Question 1

Royalty Pharma PLCの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Royalty Pharma PLCの総資産は$18,222で、純profitは$858です。

Question 2

RPRXの主要な財務比率は何ですか？

Accepted Answer

Royalty Pharma PLCの流動比率は1.61、純利益率は37.91、1株当たり売上高は$3.8です。

Question 3

Royalty Pharma PLCの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Royalty Pharma PLC data is not available.

Question 4

Royalty Pharma PLCは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Royalty Pharma PLCの純profitは$858です。

Question 5

Royalty Pharma PLCに負債はありますか？

Accepted Answer

yes、Royalty Pharma PLCの負債は11,276です。

Question 6

Royalty Pharma PLCの発行済株式数は何株ですか？

Accepted Answer

Royalty Pharma PLCの総発行済株式数は589.11株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,349	2,263	2,354	2,237	2,289	2,122
Revenue Growth (YoY)	4%	-4%	5%	-2%	8%	17%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	570	236	249	227	182	181
Research & Development	402	2	52	177	200	26
Operating Expenses	817	971	862	1,314	858	461
Other Non Operating Income (Expenses)	-8	-1	-21	-14	-5	-2
Pretax Income	1,302	1,330	1,700	230	1,241	1,702
Income Tax Expense	0	0	0	0	0	0
Net Income	764	858	1,134	42	619	495
Net Income Growth	-33%	-24%	2,600%	-93%	25%	-79%
Shares Outstanding (Diluted)	559.61	594.1	602.9	438	414.8	375.5
Shares Change (YoY)	-6%	-1%	38%	6%	10%	-37%
EPS (Diluted)	1.36	1.44	1.88	0.1	1.49	1.32
EPS Growth	-30%	-23%	1,780%	-93%	13%	-67%
Free Cash Flow	944	263	872	402	-174	-147
Free Cash Flow Per Share	1.68	0.44	1.44	0.91	-0.41	-0.39
Gross Margin	--	--	--	--	--	--
Operating Margin	65.21%	57.09%	63.38%	41.21%	62.47%	78.22%
Profit Margin	32.52%	37.91%	48.17%	1.87%	27.04%	23.32%
Free Cash Flow Margin	40.18%	11.62%	37.04%	17.97%	-7.6%	-6.92%
EBITDA	--	1,292	1,492	927	1,453	1,683
EBITDA Margin	--	57.09%	63.38%	41.43%	63.47%	79.31%
D&A For EBITDA	--	0	0	5	23	23
EBIT	1,532	1,292	1,492	922	1,430	1,660
EBIT Margin	65.21%	57.09%	63.38%	41.21%	62.47%	78.22%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Royalty Pharma PLC (RPRX) Price